Investor Sues Drug Company, Others Over Involvement In Price-Fixing Scheme

Mealey's (December 7, 2016, 9:25 AM EST) -- NEW YORK — A specialty pharmaceutical company and several of its current and former officers and directors concealed their involvement in an illegal generic drug price-fixing scheme in violation of federal...

To view the full article, register now.